Evidence map›Paper›PMID 38067655›Full record

ArticleMolecules (Basel, Switzerland)2023

Pharmacological Evidence That

Yuzuru Kubohara, Yuko Fukunaga, Haruhisa Kikuchi, Hidekazu Kuwayama

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. International journal of molecular sciences · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Yuzuru KuboharaLaboratory of Health and Life Science, Graduate School of Health and Sports Science, Juntendo University, Inzai 270-1695, Japan.ORCID 0000-0001-9231-9833
Yuko FukunagaDepartment of Animal Risk Management, Faculty of Risk and Crisis Management, Chiba Institute of Science, Choshi 288-0025, Japan.
Haruhisa KikuchiDivision of Natural Medicines, Faculty of Pharmacy, Keio University, Tokyo 105-8512, Japan.ORCID 0000-0001-6938-0185
Hidekazu KuwayamaGraduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba 305-8572, Japan.ORCID 0000-0002-4362-0790
Chiba Institute of Science · JPJuntendo University · JPKeio University · JPUniversity of Tsukuba · JP

Funding

Japan Diabetes Foundation no numberJapan Society for the Promotion of Science 19K07139the Joint Research Program of Juntendo University, Faculty of Health and Sports Science 2022B
6 · The paper itself

Abstract

Differentiation-inducing factor 1 (DIF-1) isolated from the cellular slime mold

Indexed as

Dictyostelium3T3-L1 CellsAnimalsBiological TransportGlucoseHexanonesHydrocarbons, ChlorinatedMammalsMicePhosphodiesterase Inhibitors1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanoneDifferentiation-inducing factor-1, DictyosteliumGlucoseHexanonesHydrocarbons, ChlorinatedPhosphodiesterase InhibitorscAMPdiabetesDictyostelium discoideumDIF-1forskolinobesityPDE1

Identifiers

PMID38067655
PMCPMC10708055
OpenAlexW4389310702

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.